TrialStroke2013
THRIVE score predicts outcomes with a third-generation endovascular stroke treatment device in the TREVO-2 trial.
Alexander C Flint et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
31 papers cite it
this paperpooled ittrialcites it